Dr. Filipa Lynce, MD
Claim this profileBrigham and Women's Hospital
Studies Breast Cancer
Studies Breast cancer
6 reported clinical trials
12 drugs studied
Area of expertise
1Breast Cancer
Stage IV
HER2 negative
ER negative
2Breast Cancer
Stage IV
HER2 negative
ER negative
Affiliated Hospitals
Clinical Trials Filipa Lynce, MD is currently running
Axatilimab + Olaparib
for Breast Cancer
This research is being done to evaluate the safety and tolerability of the new drug, axatilimab, in combination with olaparib (a standard of care treatment) in Breast Cancer 1/2 genes (BRCA 1/2) and PALB2 associated HER2-negative metastatic breast cancer. The names of the study drugs involved in this study are: * Axatilimab (a type of antibody) * Olaparib (a type of PARP inhibitor)
Recruiting1 award Phase 17 criteria
Trastuzumab Deruxtecan + Durvalumab
for Breast Cancer
This trial is testing a combination of two drugs, trastuzumab deruxtecan and durvalumab, for treating stage III inflammatory breast cancer that has a specific protein called HER2. The study focuses on patients who have not received previous treatment for this type of breast cancer. Trastuzumab deruxtecan targets and kills cancer cells, while durvalumab helps the immune system attack the cancer. The goal is to see if this combination is safe and effective.
Recruiting1 award Phase 215 criteria
More about Filipa Lynce, MD
Clinical Trial Related9 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Filipa Lynce, MD has experience with
- Olaparib
- Sapacitabine
- Axatilimab
- Durvalumab
- Trastuzumab Deruxtecan
- Azenosertib
Breakdown of trials Filipa Lynce, MD has run
Breast Cancer
Breast cancer
BRCA2 Mutation
Gastroesophageal Junction Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Filipa Lynce, MD specialize in?
Filipa Lynce, MD focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are HER2 negative.
Is Filipa Lynce, MD currently recruiting for clinical trials?
Yes, Filipa Lynce, MD is currently recruiting for 3 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Filipa Lynce, MD has studied deeply?
Yes, Filipa Lynce, MD has studied treatments such as Olaparib, Sapacitabine, Axatilimab.
What is the best way to schedule an appointment with Filipa Lynce, MD?
Apply for one of the trials that Filipa Lynce, MD is conducting.
What is the office address of Filipa Lynce, MD?
The office of Filipa Lynce, MD is located at: Brigham and Women's Hospital, Boston, Massachusetts 02215 United States. This is the address for their practice at the Brigham and Women's Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.